If you would like to submit a blog post for consideration, please email [email protected]
[4 min read] What surgery do patients prefer for facial melanoma and what influences their choice?
What method do patients prefer for surgical treatment of facial melanoma, and what causes patients to value the importance of surgery?
Surgical treatment options for facial melanomas include conventional excision with postoperative margin assessment, Mohs micrographic surgery with immunostains, and slow Mohs micrographic surgery.
Patient preferences for these surgical options have not been explored. Recent research enlisted participants to complete a two-part study consisting of a stated preference survey and a choice-based conjoint analysis experiment.
Patients overwhelmingly (94.3 per cent) rated local recurrence risk as very important and ranked it as the most important attribute of surgical treatment for facial melanoma. Via choice-based conjoint analysis, patients ranked the following surgical attributes from highest to lowest in importance: local recurrence rate, out-of-pocket cost, chance of second surgical visit, timing of reconstruction, travel time, and time in office for the procedure.
Consistent with their prioritisation of low local recurrence rates, more than 73 per cent of respondents selected Mohs micrographic surgery with immunostains or slow Mohs micrographic surgery as their preferred treatment option for a facial melanoma.
The study found that patients prefer surgical treatment options that minimise risk for local recurrence. Logistics for travel and treatment have less influence on patient preferences. Most survey participants chose Mohs micrographic surgery with immunostains to maximise local cure and convenience of care.